scholarly article | Q13442814 |
P356 | DOI | 10.1056/NEJMOA052434 |
P698 | PubMed publication ID | 16394298 |
P50 | author | Bruce L. Innis | Q39447629 |
Juan Pablo Yarzabal | Q56808961 | ||
Jorge Salmerón | Q58664238 | ||
Xavier Sáez-Llorens | Q68327803 | ||
Paul Gillard | Q91747664 | ||
Ricardo Rüttimann | Q106477056 | ||
P2093 | author name string | Miguel O'Ryan | |
Thomas Breuer | |||
Timo Vesikari | |||
Noris Pavía-Ruz | |||
Ralf Clemens | |||
Guillermo M Ruiz-Palacios | |||
Nadia Tornieporth | |||
Felix Espinoza | |||
Juan Carlos Tinoco | |||
Luis Rivera | |||
Alexandre C Linhares | |||
Alain Bouckenooghe | |||
Hector Abate | |||
Eduardo Ortega-Barría | |||
Brigitte Cheuvart | |||
Vesta Richardson | |||
F Raúl Velázquez | |||
Yolanda Cervantes | |||
Pío López | |||
Silvia Damaso | |||
M Lourdes Guerrero | |||
Belén Salinas | |||
Doris Maribel Rivera-Medina | |||
Béatrice De Vos | |||
Ernesto Nuñez | |||
Human Rotavirus Vaccine Study Group | |||
Irene Pérez-Schael | |||
Mercedes Macías-Parra | |||
Pilar Rubio | |||
Rodrigo F Vergara | |||
SueAnn Costa Clemens | |||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | vaccine | Q134808 |
gastroenteritis | Q156103 | ||
attenuated vaccine | Q1810913 | ||
P304 | page(s) | 11-22 | |
P577 | publication date | 2006-01-01 | |
P1433 | published in | The New England Journal of Medicine | Q582728 |
P1476 | title | Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis | |
P478 | volume | 354 |
Q38001080 | "IDEAL" vaccines for resource poor settings |
Q39344325 | 18β-glycyrrhetinic acid inhibits rotavirus replication in culture |
Q54989442 | 2. How is the economic assessment of vaccines performed today? |
Q34227701 | 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis |
Q57108439 | 6th World Congress of the World Society for Pediatric Infectious Diseases (WSPID) |
Q64136192 | A DS-1 like G9P[6] human strain CDC-6 as a new rotavirus vaccine candidate |
Q36871949 | A Randomized, Controlled Trial of the Impact of Alternative Dosing Schedules on the Immune Response to Human Rotavirus Vaccine in Rural Ghanaian Infants |
Q33455756 | A Rapid Epidemiological Tool to Measure the Burden of Norovirus Infection and Disease in Resource-Limited Settings |
Q37514764 | A critical literature review of health economic evaluations of rotavirus vaccination |
Q37547272 | A critical review on a globally-licensed, live, orally-administrable, monovalent human rotavirus vaccine: Rotarix |
Q40074888 | A cross-sectional study of acute diarrhea in Pudong, Shanghai, China: prevalence, risk factors, and healthcare-seeking practices. |
Q54401995 | A hospital based study on inter- and intragenotypic diversity of human rotavirus A VP4 and VP7 gene segments, Germany |
Q37186138 | A longitudinal cohort study in calves evaluated for rotavirus infections from 1 to 12 months of age by sequential serological assays |
Q61445443 | A milk-based self-assemble rotavirus VP6-ferritin nanoparticle vaccine elicited protection against the viral infection |
Q34029254 | A multi-center, qualitative assessment of pediatrician and maternal perspectives on rotavirus vaccines and the detection of Porcine circovirus |
Q30633803 | A multi-country study of intussusception in children under 2 years of age in Latin America: analysis of prospective surveillance data. |
Q51171028 | A new generation of carbohydrate-based therapeutics: recombinant mucin-type fusion proteins as versatile inhibitors of protein-carbohydrate interactions. |
Q48502641 | A new justification for pediatric research without the potential for clinical benefit |
Q37715611 | A new rotavirus VP6-based foreign epitope presenting vector and immunoreactivity of VP4 epitope chimeric proteins |
Q39194016 | A phase I clinical trial of a new 5-valent rotavirus vaccine |
Q114371088 | A recombinant rotavirus harboring a spike protein with a heterologous peptide reveals a novel role of VP4 in viroplasm stability |
Q37278924 | A retrospective analysis of oral cholera vaccine use, disease severity and deaths during an outbreak in South Sudan |
Q36642955 | A review of lapatinib ditosylate in the treatment of refractory or advanced breast cancer |
Q59350114 | A review of recommendations for rotavirus vaccination in Europe: Arguments for change |
Q36256433 | A significant and consistent reduction in rotavirus gastroenteritis hospitalization of children under 5 years of age, following the introduction of universal rotavirus immunization in Israel |
Q26820819 | A systematic review of anti-rotavirus serum IgA antibody titer as a potential correlate of rotavirus vaccine efficacy |
Q33517961 | A systematic review of the reporting of Data Monitoring Committees' roles, interim analysis and early termination in pediatric clinical trials |
Q40208932 | A threshold method for immunological correlates of protection |
Q54297060 | A unique human rotavirus (non vaccine) G9P4 genotype infection in a child with gastroenteritis. |
Q30935800 | Accuracy of administrative claims data to identify dose specific rotavirus vaccination information: Implications for studies of vaccine safety |
Q36732495 | Active immunization of premature and low birth-weight infants: a review of immunogenicity, efficacy, and tolerability |
Q61918194 | Active surveillance for intussusception in a phase III efficacy trial of an oral monovalent rotavirus vaccine in India |
Q40260478 | Acute diarrhea in hospitalized children of the municipality of Juiz de Fora, MG, Brazil: prevalence and risk factors associated with disease severity |
Q82789111 | Acute gastroenteritis caused by multiple enteric pathogens in children |
Q37243993 | Acute gastroenteritis in a pediatric hospital in rio de janeiro in pre- and post-rotavirus vaccination settings |
Q24676344 | Acute gastroenteritis in children |
Q36904890 | Acute infectious pediatric gastroenteritis: beyond oral rehydration therapy |
Q37285708 | Acute viral gastroenteritis in children hospitalized in Iksan, Korea during December 2010-June 2011. |
Q55381145 | Adoption of rotavirus vaccine by U.S. physicians: progress and challenges. |
Q45397864 | Amount of maternal rotavirus-specific antibodies influence the outcome of rotavirus vaccination of newborn mice with virus-like particles. |
Q36000457 | An Exopolysaccharide-Deficient Mutant of Lactobacillus rhamnosus GG Efficiently Displays a Protective Llama Antibody Fragment against Rotavirus on Its Surface |
Q83842085 | An economic analysis of rotavirus vaccination in Italy |
Q56764214 | An optimal vaccination strategy against rotavirus |
Q57929860 | An update from hospital-based surveillance for rotavirus gastroenteritis among young children in Bangladesh, July 2012 to June 2017 |
Q37762543 | An update on management of severe acute infectious gastroenteritis in children. |
Q43716574 | Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine |
Q26783530 | Anti-infective vaccination in the 21st century-new horizons for personal and public health |
Q38467394 | Antigenemia, RNAemia, and innate immunity in children with acute rotavirus diarrhea |
Q92320554 | Antirotavirus IgA seroconversion rates in children who receive concomitant oral poliovirus vaccine: A secondary, pooled analysis of Phase II and III trial data from 33 countries |
Q58892227 | Assessing the introduction of universal rotavirus vaccination in the Netherlands |
Q96586351 | Assessment of risk of intussusception after pilot rollout of rotavirus vaccine in the Indian public health system |
Q90481177 | Association Between Rotavirus Vaccination and Risk of Intussusception Among Neonates and Infants: A Systematic Review and Meta-analysis |
Q36684586 | Association of Maternal Immunity with Rotavirus Vaccine Immunogenicity in Zambian Infants. |
Q90327621 | Association of Rotavirus Vaccination With Inpatient and Emergency Department Visits Among Children Seeking Care for Acute Gastroenteritis, 2010-2016 |
Q37713807 | Association of rotavirus strains and severity of gastroenteritis in Indian children |
Q34290838 | Association of serum anti-rotavirus immunoglobulin A antibody seropositivity and protection against severe rotavirus gastroenteritis: analysis of clinical trials of human rotavirus vaccine. |
Q30491496 | Background rates of disease in Latin American children from a rotavirus vaccine study |
Q30773449 | Bayesian network meta-analysis suggests a similar effectiveness between a monovalent and a pentavalent rotavirus vaccine: a preliminary report of re-analyses of data from a Cochrane Database Systematic Review |
Q31146806 | Beyond expectations: Post-implementation data shows rotavirus vaccination is likely cost-saving in Australia. |
Q40567834 | Breastfeeding linked to the reduction of both rotavirus shedding and IgA levels after Rotarix® immunization in Mexican infants |
Q46790602 | Broadening the age restriction for initiating rotavirus vaccination in regions with high rotavirus mortality: benefits of mortality reduction versus risk of fatal intussusception |
Q36455793 | Burden of Norovirus and Rotavirus in Children After Rotavirus Vaccine Introduction, Cochabamba, Bolivia |
Q36887357 | Burden of disease & molecular epidemiology of group A rotavirus infections in India |
Q33495433 | Burden of disease and circulating serotypes of rotavirus infection in sub-Saharan Africa: systematic review and meta-analysis. |
Q34115533 | Burden of rotavirus gastroenteritis and distribution of rotavirus strains in Asia: a systematic review |
Q44766361 | Burden of severe rotavirus disease in Australia. |
Q43822269 | Burden on UK secondary care of rotavirus disease and seasonal infections in children |
Q57808456 | Case-Control Study of Rotavirus Vaccine Effectiveness Compared to Test-Negative Controls or Hospital Controls |
Q57097648 | Case-control evaluation of the effectiveness of the G1P[8] human rotavirus vaccine during an outbreak of rotavirus G2P[4] infection in central Australia |
Q47794110 | Causes of impaired oral vaccine efficacy in developing countries. |
Q38808226 | Challenges in conducting post-authorisation safety studies (PASS): A vaccine manufacturer's view |
Q40354451 | Change in incidence of clinic visits for all-cause and rotavirus gastroenteritis in young children following the introduction of universal rotavirus vaccination in Israel |
Q34574440 | Changes in childhood diarrhea incidence in nicaragua following 3 years of universal infant rotavirus immunization |
Q37175169 | Changing epidemiology of rotavirus-related hospitalizations in rio de janeiro, Brazil, from 2002 to 2006. |
Q41371547 | Changing patterns of rotavirus strains circulating in Ireland: re-emergence of G2P[4] and identification of novel genotypes in Ireland |
Q34820154 | Changing profile of rotavirus genotypes in Bangladesh, 2006-2012 |
Q36584400 | Chapter 27: Research needs following initial licensure of virus-like particle HPV vaccines |
Q43797814 | Characteristics of an ideal rotavirus vaccine |
Q34018952 | Characterization of a G1P[8] rotavirus causing an outbreak of gastroenteritis in the Northern Territory, Australia, in the vaccine era. |
Q35019757 | Characterization of in vivo anti-rotavirus activities of saponin extracts from Quillaja saponaria Molina |
Q33768166 | Child feeding practices and diarrheal disease among children less than two years of age of the nomadic people in Hadaleala District, Afar Region, Northeast Ethiopia. |
Q36155443 | Childhood immunisation: what is the future? |
Q34275545 | Chimaeric virus-like particles derived from consensus genome sequences of human rotavirus strains co-circulating in Africa |
Q56787288 | Clinical Characteristics of Nosocomial Rotavirus Infection in Children in Taiwan |
Q39991868 | Clinical Severity and Rotavirus Vaccination among Children Hospitalized for Acute Gastroenteritis in Belém, Northern Brazil |
Q36978372 | Clinical and cost burden of rotavirus infection before and after introduction of rotavirus vaccines among commercially and Medicaid insured children in the United States |
Q36896314 | Clinical update: rotavirus gastroenteritis and its prevention |
Q37089583 | Community diarrhea incidence before and after rotavirus vaccine introduction in Nicaragua |
Q99606951 | Comparative evaluation of prophylactic SIV vaccination modalities administered to the oral cavity |
Q33934529 | Comparative evaluation of the potential impact of rotavirus versus HPV vaccination in GAVI-eligible countries: a preliminary analysis focused on the relative disease burden |
Q37530403 | Comparative immunogenicity in mice of rotavirus VP6 tubular structures and virus-like particles |
Q33955841 | Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world |
Q34719720 | Comparative study of the epidemiology of rotavirus in children from a community-based birth cohort and a hospital in South India |
Q81955561 | Comparison between two severity scoring scales commonly used in the evaluation of rotavirus gastroenteritis in children |
Q37085086 | Comparison of 2 assays for diagnosing rotavirus and evaluating vaccine effectiveness in children with gastroenteritis |
Q41463942 | Comparison of Vesikari and Clark scales regarding the definition of severe rotavirus gastroenteritis in children |
Q28257258 | Comparison of impact and cost-effectiveness of rotavirus supplementary and routine immunization in a complex humanitarian emergency, Somali case study |
Q47832345 | Comparison of two clinical severity scoring systems in two multi-center, developing country rotavirus vaccine trials in Africa and Asia |
Q34077813 | Complete genome sequence analysis of candidate human rotavirus vaccine strains RV3 and 116E |
Q33848262 | Compliance of mothers following recommendations to breastfeed or withhold breast milk during rotavirus vaccination in North India: a randomized clinical trial |
Q36157186 | Complicated norovirus infection and assessment of severity by a modified Vesikari disease score system in hospitalized children |
Q45281590 | Complications attributable to rotavirus-induced diarrhoea in a Swedish paediatric population: report from an 11-year surveillance |
Q84744021 | Complications in hospitalized children with acute gastroenteritis caused by rotavirus: a retrospective analysis |
Q59360996 | Composition of gut microbiota and its influence on the immunogenicity of oral rotavirus vaccines |
Q83798707 | Conclusion on cost-effectiveness of rotavirus vaccination highly dependent on assumptions |
Q41546108 | Conquering rotavirus: from discovery to global vaccine implementation |
Q38033977 | Consensus recommendations on immunization and IAP immunization timetable 2012. |
Q37563622 | Contribution of Maternal Immunity to Decreased Rotavirus Vaccine Performance in Low- and Middle-Income Countries |
Q38281298 | Correlates of protection against human rotavirus disease and the factors influencing protection in low-income settings |
Q38683902 | Correlates of protection for enteric vaccines |
Q35886464 | Correlates of protection for rotavirus vaccines: Possible alternative trial endpoints, opportunities, and challenges |
Q46414053 | Cost analysis of care for children admitted to kenyatta national hospital with rotavirus gastroenteritis |
Q56793962 | Cost and cost-effectiveness of childhood vaccination against rotavirus in France |
Q38573098 | Cost effectiveness evaluation of a rotavirus vaccination program in Argentina |
Q36111776 | Cost effectiveness of infant vaccination for rotavirus in Canada |
Q47861443 | Cost-effectiveness analysis of introducing universal childhood rotavirus vaccination in Bangladesh. |
Q41279252 | Cost-effectiveness analysis of rotavirus vaccination in Argentina |
Q33401714 | Cost-effectiveness of Rotavirus vaccination in Vietnam |
Q37398811 | Cost-effectiveness of a new rotavirus vaccination program in Pakistan: a decision tree model |
Q44938367 | Cost-effectiveness of childhood rotavirus vaccination in Taiwan |
Q34740340 | Cost-effectiveness of rotavirus immunization in Indonesia: taking breastfeeding patterns into account |
Q38864030 | Cost-effectiveness of rotavirus vaccination in Albania |
Q35166897 | Cost-effectiveness of rotavirus vaccination in Bolivia from the state perspective |
Q38551664 | Cost-effectiveness of rotavirus vaccination: exploring caregiver(s) and "no medical care'' disease impact in Belgium |
Q86694278 | Cost-effectiveness of rotavirus vaccines in British Columbia: Responding to: Fisman DN, Chan CH, Lowcock E, Naus M, Lee V. Effectiveness and cost-effectiveness of pediatric rotavirus vaccination in British Columbia: A model-based evaluation [Vaccine |
Q48616571 | Cost-effectiveness of universal rotavirus vaccination in reducing rotavirus gastroenteritis in Ireland |
Q91878464 | Current and new rotavirus vaccines |
Q38603768 | Current status of rotavirus vaccines |
Q37420608 | Decline in Emergency Department Visits for Acute Gastroenteritis Among Children in 10 US States After Implementation of Rotavirus Vaccination, 2003 to 2013. |
Q45339666 | Decline in Rotavirus Hospitalizations and Health Care Visits for Childhood Diarrhea Following Rotavirus Vaccination in El Salvador |
Q42007674 | Decline in cases of rotavirus gastroenteritis presenting to The Children's Hospital of Philadelphia after introduction of a pentavalent rotavirus vaccine |
Q33883799 | Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization in Brazil: a time-series analysis |
Q51157393 | Decline in rotavirus hospitalisations following introduction of Australia's national rotavirus immunisation programme. |
Q47291480 | Decreased performance of live attenuated, oral rotavirus vaccines in low-income settings: causes and contributing factors |
Q30276748 | Delayed Dosing of Oral Rotavirus Vaccine Demonstrates Decreased Risk of Rotavirus Gastroenteritis Associated With Serum Zinc: A Randomized Controlled Trial |
Q34441419 | Demographic variability, vaccination, and the spatiotemporal dynamics of rotavirus epidemics |
Q34663993 | Dengue vaccine trial guidelines and role of large-scale, post proof-of-concept demonstration projects in bringing a dengue vaccine to use in dengue endemic areas |
Q46077494 | Des recommandations quant à l’usage des vaccins antirotavirus chez les nourrissons |
Q41859722 | Detection and characterization of group C rotaviruses in asymptomatic piglets in Ireland |
Q54386651 | Detection and characterization of human rotavirus in hospitalized patients in the cities of Ponta Grossa, Londrina and Assai - PR, Brazil. |
Q42158105 | Detection and genetic characterization of group A rotavirus strains circulating among children with acute gastroenteritis in Japan |
Q41875733 | Detection and genotyping of human rotavirus VP4 and VP7 genes by reverse transcriptase PCR and reverse hybridization |
Q38974879 | Detection of Common, Emerging and Uncommon VP4, and VP7 Human Group A Rotavirus Genotypes from Urban Sewage Samples in Uruguay |
Q54373306 | Detection of G3P[3] and G3P[9] rotavirus strains in American Indian children with evidence of gene reassortment between human and animal rotaviruses. |
Q36075467 | Detection of Rotavirus Genotypes in Korea 5 Years after the Introduction of Rotavirus Vaccines |
Q42282843 | Detection of unusual G6 rotavirus strains in Italian children with diarrhoea during the 2011 surveillance season. |
Q36452525 | Development of a microtiter plate hybridization-based PCR-enzyme-linked immunosorbent assay for identification of clinically relevant human group A rotavirus G and P genotypes |
Q37652537 | Development of a rotavirus vaccine: clinical safety, immunogenicity, and efficacy of the pentavalent rotavirus vaccine, RotaTeq |
Q30425503 | Development of a stable insect cell line constitutively expressing rotavirus VP2. |
Q38211748 | Diagnosis of viral gastroenteritis in children: interpretation of real-time PCR results and relation to clinical symptoms |
Q38174842 | Diagnosis, management, and prevention of rotavirus gastroenteritis in children |
Q33763060 | Diarrhea: case definition and guidelines for collection, analysis, and presentation of immunization safety data |
Q42221656 | Diarrhoea caused by rotavirus in a regional Peruvian hospital: determination of circulating genotypes |
Q37630158 | Diarrhoea-related hospitalizations in children before and after implementation of monovalent rotavirus vaccination in Mexico |
Q46243057 | Differences of Rotavirus Vaccine Effectiveness by Country: Likely Causes and Contributing Factors |
Q36175693 | Differential profiles and inhibitory effect on rotavirus vaccines of nonantibody components in breast milk from mothers in developing and developed countries |
Q31086859 | Direct and indirect effects of rotavirus vaccination: comparing predictions from transmission dynamic models |
Q59134865 | Direct and possible indirect effects of vaccination on rotavirus hospitalisations among children in Malawi four years after programmatic introduction |
Q37671911 | Direct, indirect, total, and overall effectiveness of the rotavirus vaccines for the prevention of gastroenteritis hospitalizations in privately insured US children, 2007-2010. |
Q64131818 | Disease and economic burden of rotavirus diarrhoea in India |
Q40227460 | Dissemination of gastroenteric viruses in the production of lettuce in developing countries: a public health concern |
Q51172197 | Distribution of rotavirus genotypes causing nosocomial and community-acquired acute gastroenteritis at the Children's Hospital of Philadelphia in the new rotavirus vaccine era. |
Q92051384 | Distribution of rotavirus genotypes in Japan from 2015 to 2018: Diversity in genotypes before and after introduction of rotavirus vaccines |
Q38235912 | Distribution of rotavirus strains and strain-specific effectiveness of the rotavirus vaccine after its introduction: a systematic review and meta-analysis |
Q45338061 | Distributional impact of rotavirus vaccination in 25 GAVI countries: estimating disparities in benefits and cost-effectiveness. |
Q37296744 | Diversity in Rotavirus-Host Glycan Interactions: A "Sweet" Spectrum |
Q38903522 | Diversity of rotavirus strains circulating in children under 5 years of age admitted to hospital for acute gastroenteritis in Morocco, June 2006 to May 2009. |
Q36175711 | Dose sparing and enhanced immunogenicity of inactivated rotavirus vaccine administered by skin vaccination using a microneedle patch |
Q38242111 | Early childhood diarrhoeal diseases and cognition: are we missing the rest of the iceberg? |
Q34669133 | Early exposure of infants to natural rotavirus infection: a review of studies with human rotavirus vaccine RIX4414. |
Q40106056 | Early impact of rotavirus vaccine in under 5year old children hospitalized due to diarrhea, Swaziland |
Q92736703 | Economic Evaluation of Human Rotavirus Vaccine in Thailand |
Q64126208 | Economic analysis for evidence-based policy-making on a national immunization program: a case of rotavirus vaccine in Thailand |
Q47856401 | Economic burden of rotavirus disease in children under 5 years in Kazakhstan. |
Q30909743 | Economic evaluation of a routine rotavirus vaccination programme in Indonesia |
Q40496831 | Economic evaluation of routine infant rotavirus immunisation program in Japan |
Q102319163 | Economic evaluation of the introduction of rotavirus vaccine in Hong Kong |
Q37909422 | Economic evaluations of rotavirus immunization for developing countries: a review of the literature. |
Q37339643 | Economic impact of a rotavirus vaccine in Brazil |
Q45260893 | Editorial commentary: intussusception and rotavirus vaccination--balancing risk against benefit |
Q37668175 | Effect of breastfeeding on immunogenicity of oral live-attenuated human rotavirus vaccine: a randomized trial in HIV-uninfected infants in Soweto, South Africa |
Q37425479 | Effect of human rotavirus vaccine on severe diarrhea in African infants |
Q47546357 | Effect of innate antiviral glycoproteins in breast milk on seroconversion to rotavirus vaccine (Rotarix) in children in Lusaka, Zambia |
Q38903517 | Effect of monovalent rotavirus vaccine on rotavirus disease burden and circulating rotavirus strains among children in Morocco |
Q40045569 | Effect of pentavalent rotavirus vaccine introduction on hospital admissions for diarrhoea and rotavirus in children in Rwanda: a time-series analysis |
Q44217323 | Effect of rotavirus vaccination on circulating virus strains |
Q40791967 | Effect of rotavirus vaccine on childhood diarrhea mortality in five Latin American countries |
Q46195093 | Effectiveness and cost-effectiveness of pediatric rotavirus vaccination in British Columbia: a model-based evaluation |
Q38176032 | Effectiveness and impact of rotavirus vaccines in the United States - 2006-2012. |
Q92252858 | Effectiveness of Lanzhou lamb rotavirus vaccine in preventing gastroenteritis among children younger than 5 years of age |
Q40722616 | Effectiveness of Monovalent Rotavirus Vaccine After Programmatic Implementation in Botswana: A Multisite Prospective Case-Control Study |
Q40722658 | Effectiveness of Monovalent and Pentavalent Rotavirus Vaccines in Guatemala. |
Q39512394 | Effectiveness of Pentavalent Rotavirus Vaccine Under Conditions of Routine Use in Rwanda |
Q36356363 | Effectiveness of Rotavirus Vaccination: A systematic review of the first decade of global post-licensure data, 2006-2016. |
Q46443685 | Effectiveness of childhood vaccination against rotavirus in sub-Saharan Africa: the case of Nigeria |
Q33819513 | Effectiveness of monovalent and pentavalent rotavirus vaccine |
Q90423869 | Effectiveness of monovalent and pentavalent rotavirus vaccines in Japanese children |
Q40227989 | Effectiveness of monovalent human rotavirus vaccine against admission to hospital for acute rotavirus diarrhoea in South African children: a case-control study |
Q36942818 | Effectiveness of monovalent rotavirus vaccine in Bolivia: case-control study |
Q92437369 | Effectiveness of oral rotavirus vaccination in England against rotavirus-confirmed and all-cause acute gastroenteritis |
Q36201304 | Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011 |
Q33915516 | Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study |
Q36149373 | Effectiveness of rotavirus vaccination in prevention of hospital admissions for rotavirus gastroenteritis among young children in Belgium: case-control study |
Q37452293 | Effectiveness of rotavirus vaccine in preventing hospitalization due to rotavirus gastroenteritis in young children in Connecticut, USA. |
Q37375983 | Effectiveness of rotavirus vaccine in preventing severe gastroenteritis in young children according to socioeconomic status |
Q26741847 | Effectiveness of rotavirus vaccines against rotavirus infection and hospitalization in Latin America: systematic review and meta-analysis |
Q93034346 | Effectiveness of rotavirus vaccines in an Australian population: A case-control study |
Q82707061 | Effectiveness of rotavirus vaccines in preventing cases and hospitalizations due to rotavirus gastroenteritis in Navarre, Spain |
Q35154120 | Effectiveness of rotavirus vaccines, licensed but not funded, against rotavirus hospitalizations in the Valencia Region, Spain |
Q59810627 | Effectiveness of the Oral Human Attenuated Rotavirus Vaccine: A Systematic Review and Meta-analysis-2006-2016 |
Q36245512 | Effectiveness of the live attenuated rotavirus vaccine produced by a domestic manufacturer in China studied using a population-based case-control design |
Q42227014 | Effectiveness of the monovalent rotavirus vaccine in Colombia: a case-control study |
Q89580859 | Effects of rotavirus vaccine on all-cause acute gastroenteritis and rotavirus hospitalizations in Israel: A nationwide analysis |
Q46390356 | Efficacy and immunogenicity of two or three dose rotavirus-vaccine regimen in South African children over two consecutive rotavirus-seasons: a randomized, double-blind, placebo-controlled trial. |
Q44881283 | Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study |
Q34432275 | Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian children in the second year of life |
Q35941163 | Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial |
Q79958029 | Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study |
Q37695264 | Efficacy of human rotavirus vaccine against severe gastroenteritis in Malawian children in the first two years of life: a randomized, double-blind, placebo controlled trial |
Q92615046 | Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trials |
Q39944921 | Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial |
Q46793235 | Efficacy of the oral pentavalent rotavirus vaccine in Mali |
Q36974911 | Efficacy, immunogenicity, and safety of two doses of a tetravalent rotavirus vaccine RRV-TV in Ghana with the first dose administered during the neonatal period |
Q36249319 | Efficacy, safety and effectiveness of licensed rotavirus vaccines: a systematic review and meta-analysis for Latin America and the Caribbean. |
Q84273141 | Efficacy, safety and immunogenicity of RIX4414 in Japanese infants during the first two years of life |
Q61700300 | Efficacy, safety and immunogenicity of a human rotavirus vaccine (RIX4414) in Hong Kong children up to three years of age: A randomized, controlled trial |
Q36539869 | Emergence of G12 rotavirus strains in Delhi, India, in 2000 to 2007. |
Q47595679 | Emergence of G9P[8] rotaviruses in children with acute gastroenteritis in Thailand, 2015-2016. |
Q36377394 | Emergence of Rotavirus G12P[8] in St. Louis During the 2012-2013 Rotavirus Season |
Q37411814 | Emergence of human G2P[4] rotaviruses containing animal derived gene segments in the post-vaccine era. |
Q33430511 | Emergence of unusual human rotavirus strains in Salento, Italy, during 2006-2007 |
Q36440493 | Emerging vaccines: evidence and considerations for practice integration. |
Q91360178 | Enhancing immune responses to oral vaccines: still an enigma |
Q30443288 | Enteric infections, diarrhea, and their impact on function and development |
Q47561564 | Enteric viruses in surface waters from Argentina: molecular and viable virus detection |
Q35910518 | Enteropathies in the developing world: neglected effects on global health |
Q44521566 | Epidemiology and clinical features of gastroenteritis in hospitalised children: prospective survey during a 2-year period in a Parisian hospital, France. |
Q45252066 | Epidemiology and economic burden of rotavirus gastroenteritis in hospitals and paediatric clinics in Taiwan, 2005-2006. |
Q40202918 | Epidemiology and genetic diversity of classic human astrovirus among hospitalized children with acute gastroenteritis in Uruguay |
Q34795202 | Epidemiology and genetic diversity of rotavirus strains in children with acute gastroenteritis in Lahore, Pakistan |
Q34288174 | Epidemiology and prospects for prevention of rotavirus disease in India |
Q64137674 | Epidemiology of acute diarrhea caused by rotavirus in sentinel surveillance sites of Vietnam, 2012-2015 |
Q48529071 | Epidemiology of childhood intussusception in Bangladesh: Findings from an active national hospital based surveillance system, 2012-2016. |
Q33776112 | Epidemiology of rotavirus infection among young children with acute diarrhoea in Burkina Faso |
Q51129407 | Epidemiology of rotavirus-associated hospital admissions in the province of Ferrara, Italy. |
Q30276185 | Epidemiology, Seasonality and Factors Associated with Rotavirus Infection among Children with Moderate-to-Severe Diarrhea in Rural Western Kenya, 2008-2012: The Global Enteric Multicenter Study (GEMS) |
Q36310196 | Estimated hospitalizations attributed to norovirus and rotavirus infection in Canada, 2006-2010. |
Q49797351 | Estimated impact of rotavirus vaccine on hospitalizations and deaths from rotavirus diarrhea among children <5 in Asia |
Q37365715 | Estimated mortality and hospital admission due to rotavirus infection in the WHO European region. |
Q38612845 | Estimated reductions in hospitalizations and deaths from childhood diarrhea following implementation of rotavirus vaccination in Africa. |
Q36774675 | Estimates of the economic burden of rotavirus-associated and all-cause diarrhoea in Vellore, India |
Q46790381 | Estimating rotavirus gastroenteritis hospitalisations by using hospital episode statistics before and after the introduction of rotavirus vaccine in Australia |
Q47005046 | Estimating the incidence of rotavirus infection in children from India and Malawi from serial anti-rotavirus IgA titres |
Q40110796 | Estimating the public health importance of the CYD-tetravalent dengue vaccine: Vaccine preventable disease incidence and numbers needed to vaccinate |
Q63881009 | Etiología y manejo de la gastroenteritis aguda infecciosa en niños y adultos |
Q50801671 | Evaluating rotavirus vaccination in England and Wales. Part I. Estimating the burden of disease. |
Q53198731 | Evaluating rotavirus vaccination in England and Wales. Part II. The potential cost-effectiveness of vaccination. |
Q92623430 | Evaluating strategies to improve rotavirus vaccine impact during the second year of life in Malawi |
Q35909569 | Evaluating the Impact of Breastfeeding on Rotavirus Antigenemia and Disease Severity in Indian Children |
Q39037610 | Evaluating the first introduction of rotavirus vaccine in Thailand: Moving from evidence to policy |
Q38947795 | Evaluating the potential risks and benefits of infant rotavirus vaccination in England. |
Q92267944 | Evaluation of Intussusception After Oral Monovalent Rotavirus Vaccination in South Africa |
Q43687125 | Evaluation of cost-effectiveness of live oral pentavalent reassortant rotavirus vaccine introduction in Ghana |
Q51157129 | Evaluation of potential medical and economic benefits of universal rotavirus vaccination in Greece. |
Q35947992 | Evaluation of the Intussusception Risk after Pentavalent Rotavirus Vaccination in Finnish Infants |
Q35137102 | Evaluation of vaccines against enteric infections: a clinical and public health research agenda for developing countries |
Q43662952 | Evidence of interspecies transmission and reassortment among avian group A rotaviruses |
Q42638130 | Evidence of intragenic recombination in G1 rotavirus VP7 genes |
Q41046228 | Evolution of human G4P[8] group A rotavirus strains circulating in Italy in 2013. |
Q35784668 | Evolutionary history and global spread of the emerging g12 human rotaviruses |
Q64130682 | Experiences with rotavirus vaccines: can we improve rotavirus vaccine impact in developing countries? |
Q31137956 | Experimental pathways towards developing a rotavirus reverse genetics system: synthetic full length rotavirus ssRNAs are neither infectious nor translated in permissive cells |
Q48188462 | Exploring model uncertainty in economic evaluation of health interventions: the example of rotavirus vaccination in Vietnam |
Q36750239 | Exploring the cost effectiveness of an immunization programme for rotavirus gastroenteritis in the United Kingdom |
Q57178120 | Exploring the relationship between environmental enteric dysfunction and oral vaccine responses |
Q37395367 | FIRST MOLECULAR DETECTION AND VP7 (G) GENOTYPING OF GROUP A ROTAVIRUS BY SEMI-NESTED RT-PCR FROM SEWAGE IN NIGERIA. |
Q40038509 | Factors associated with rotavirus diarrhoea in children living in a socially diverse urban centre in Brazil |
Q44960518 | Financing children's vaccines |
Q38039625 | Financing vaccinations - the South African experience |
Q90003463 | First assessment of all-cause acute diarrhoea and rotavirus-confirmed cases following massive vaccination in Argentina |
Q44800567 | First year experience of rotavirus immunisation programme in Finland |
Q38998392 | Formation of self-assembled triple-layered rotavirus-like particles (tlRLPs) by constitutive co-expression of VP2, VP6, and VP7 in stably transfected high-five insect cell lines |
Q46523533 | Fractional polynomial adjustment for time-varying covariates in a self-controlled case series analysis |
Q43981036 | From structural and antigenic features of the rotavirus to the development of the vaccines |
Q38022320 | Fulfilling the promise of rotavirus vaccines: how far have we come since licensure? |
Q64251302 | GII.4 Human Norovirus: Surveying the Antigenic Landscape |
Q84500544 | Gastroenteritis in children |
Q84595951 | Gastroenteritis in children |
Q37233997 | Gastroenterology in developing countries: issues and advances |
Q90345224 | Genetic Diversity of Human Rotavirus A Among Hospitalized Children Under-5 Years in Lebanon |
Q35806976 | Genetic analyses reveal differences in the VP7 and VP4 antigenic epitopes between human rotaviruses circulating in Belgium and rotaviruses in Rotarix and RotaTeq |
Q36181323 | Genetic analysis of G12P[8] rotaviruses detected in the largest U.S. G12 genotype outbreak on record |
Q40693225 | Genetic variability of VP7, VP4, VP6 and NSP4 genes of common human G1P[8] rotavirus strains circulating in Italy between 2010 and 2014. |
Q36172686 | Genetically modified enterotoxigenic Escherichia coli vaccines induce mucosal immune responses without inflammation. |
Q41350844 | Genomic analysis of codon, sequence and structural conservation with selective biochemical-structure mapping reveals highly conserved and dynamic structures in rotavirus RNAs with potential cis-acting functions |
Q41988136 | Genomic characterization of nontypeable rotaviruses and detection of a rare G8 strain in Delhi, India. |
Q33788195 | Genotype diversity and molecular evolution of noroviruses: A 30-year (1982-2011) comprehensive study with children from Northern Brazil |
Q39987262 | Genotype diversity of group A rotavirus strains in children with acute diarrhea in urban Burkina Faso, 2008-2010 |
Q39746335 | Genotypes of rotavirus strains circulating in Amman, Jordan, in 2006/07 and their significance for the potential effectiveness of future rotavirus vaccination |
Q38975432 | Genotypic Distribution of Rotavirus in Phnom Penh, Cambodia: An Association of G9 with More Severe Diseases |
Q79754020 | Genotypic characterization of rotaviruses and prevalence of serotype-specific serum antibodies in children in Kuwait |
Q54343219 | Genotyping of human rotaviruses circulating among children with diarrhea in Valencia, Venezuela. |
Q35482824 | Genotyping rotavirus RNA from archived rotavirus-positive rapid test strips |
Q38826540 | Global Impact of Rotavirus Vaccination on Childhood Hospitalizations and Mortality from Diarrhea |
Q36371703 | Global economic evaluations of rotavirus vaccines: A systematic review |
Q34108591 | Global impact of rotavirus vaccines |
Q34299983 | Global issues related to enteric viral infections |
Q37369942 | Group A rotavirus genotypes and the ongoing Brazilian experience: a review |
Q64054487 | Group A rotavirus surveillance before vaccine introduction in Italy, September 2014 to August 2017 |
Q38068232 | Group A rotavirus universal mass vaccination: how and to what extent will selective pressure influence prevalence of rotavirus genotypes? |
Q28388806 | Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective |
Q40722565 | Health Impact of Rotavirus Vaccination in Developing Countries: Progress and Way Forward |
Q33578406 | Health and economic impact of rotavirus vaccination in GAVI-eligible countries |
Q47573959 | Health economics of rotavirus immunization in Vietnam: potentials for favorable cost-effectiveness in developing countries |
Q46614284 | Health impact and cost-effectiveness of a domestically-produced rotavirus vaccine in India: A model based analysis. |
Q53409378 | Healthy-days time equivalents for outcomes of acute rotavirus infections. |
Q92203456 | Heterogeneous susceptibility to rotavirus infection and gastroenteritis in two birth cohort studies: Parameter estimation and epidemiological implications |
Q30234848 | Histo-blood group antigens as receptors for rotavirus, new understanding on rotavirus epidemiology and vaccine strategy |
Q58438692 | Hospital acquired rotavirus infections: burden in Canadian paediatric hospitals |
Q37591888 | Hospital-based Surveillance for Rotavirus Gastroenteritis Among Young Children in Bangladesh: Defining the Potential Impact of a Rotavirus Vaccine Program |
Q44595188 | Hospital-based surveillance for rotavirus diarrhoea in Phnom Penh, Cambodia, March 2005 through February 2007. |
Q37552299 | Hospital-based surveillance of rotavirus gastroenteritis among children under 5 years of age in the Republic of Ivory Coast: a cross-sectional study. |
Q33794728 | Hospital-based surveillance to estimate the burden of rotavirus gastroenteritis in children below five years of age in Romania |
Q33726130 | Hospitalisation for rotavirus gastroenteritis in the paediatric population in the Veneto Region, Italy |
Q36235204 | Hospitalizations for intussusception before and after the reintroduction of rotavirus vaccine in the United States |
Q36997199 | Household transmission of rotavirus in a community with rotavirus vaccination in Quininde, Ecuador |
Q39066570 | Human P[6] Rotaviruses From Sub-Saharan Africa and Southeast Asia Are Closely Related to Those of Human P[4] and P[8] Rotaviruses Circulating Worldwide. |
Q40211513 | Human and bovine rotavirus strain antigens for evaluation of immunogenicity in a randomized, double-blind, placebo-controlled trial of a single dose live attenuated tetravalent, bovine-human-reassortant, oral rotavirus vaccine in Indian adults |
Q33644772 | Human infection with G12 rotaviruses, Germany |
Q35792185 | Human rotavirus G9 and G3 as major cause of diarrhea in hospitalized children, Spain |
Q35109584 | Human rotavirus group a serotypes causing gastroenteritis in children less than 5 years and HIV-infected adults in Viwandani slum, Nairobi |
Q36026167 | Human rotavirus serotype G9, São Paulo, Brazil, 1996-2003 |
Q37713426 | Human rotavirus strains circulating in Venezuela after vaccine introduction: predominance of G2P[4] and reemergence of G1P[8]. |
Q34271468 | Human rotavirus vaccine (RIX4414) efficacy in the first two years of life: a randomized, placebo-controlled trial in China |
Q38534245 | Human rotavirus vaccine (Rotarix): focus on effectiveness and impact 6 years after first introduction in Africa |
Q36291026 | Human rotavirus vaccine Rotarix™ provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial. |
Q81037003 | Human rotavirus vaccines: too early for the strain to tell |
Q38081968 | Human rotavirus virus-like particle vaccines evaluated in a neonatal gnotobiotic pig model of human rotavirus disease |
Q79872372 | Identification of an immunodominant CD4+ T cell epitope in the VP6 protein of rotavirus following intranasal immunization of BALB/c mice |
Q46008918 | Identification of lineage III of G12 rotavirus strains in diarrheic children in the Northern Region of Brazil between 2008 and 2010. |
Q44793215 | Identification of two sublineages of genotype G2 rotavirus among diarrheic children in Parauapebas, Southern Pará State, Brazil |
Q38059916 | Immune responses and protection in children in developing countries induced by oral vaccines |
Q34291161 | Immune responses elicited against rotavirus middle layer protein VP6 inhibit viral replication in vitro and in vivo. |
Q24626023 | Immune responses to rotavirus infection and vaccination and associated correlates of protection |
Q36728581 | Immunization in Canada: Update for 2015. |
Q81401502 | Immunization update |
Q37646974 | Immunization update II. |
Q21245322 | Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine |
Q37473348 | Immunogenicity and protective efficacy of rotavirus VP8* fused to cholera toxin B subunit in a mouse model |
Q37134934 | Immunogenicity and reactogenicity of the human rotavirus vaccine, RIX4414 oral suspension, when co-administered with routine childhood vaccines in Chinese infants |
Q91747670 | Immunogenicity and safety of the diphtheria, pertussis, tetanus and inactivated poliovirus vaccine when co-administered with the human rotavirus vaccine (Rotarix) in healthy Japanese infants: a phase IV randomized study |
Q84384797 | Immunogenicity and safety of the human rotavirus vaccine Rotarix co-administered with routine infant vaccines following the vaccination schedules in Europe |
Q44773885 | Immunogenicity and virus-like particle formation of rotavirus capsid proteins produced in transgenic plants |
Q42201983 | Immunogenicity of a three dose and five dose oral human rotavirus vaccine (RIX4414) schedule in south Indian infants |
Q47832209 | Immunogenicity of the pentavalent rotavirus vaccine in African infants |
Q83267580 | Immunogenicity, reactogenicity and safety of the human rotavirus vaccine RIX4414 (Rotarix™) oral suspension (liquid formulation) when co-administered with expanded program on immunization (EPI) vaccines in Vietnam and the Philippines in 2006-2007 |
Q28972559 | Immunology of Gut Mucosal Vaccines |
Q36781552 | Impact of Rotavirus Vaccination on Hospitalizations and Deaths From Childhood Gastroenteritis in Botswana |
Q42210076 | Impact of different dosing schedules on the immunogenicity of the human rotavirus vaccine in infants in Pakistan: a randomized trial |
Q33682584 | Impact of emergency department probiotic treatment of pediatric gastroenteritis: study protocol for the PROGUT (Probiotic Regimen for Outpatient Gastroenteritis Utility of Treatment) randomized controlled trial |
Q50147691 | Impact of five years of rotavirus vaccination in Finland - And the associated cost savings in secondary healthcare. |
Q37530039 | Impact of rotavirus vaccination in Australian children below 5 years of age: a database study |
Q36864913 | Impact of rotavirus vaccination in regions with low and moderate vaccine uptake in Germany |
Q58232513 | Impact of rotavirus vaccination on diarrhoea mortality and hospital admissions in Brazil |
Q59176456 | Impact of rotavirus vaccination on hospitalizations for rotavirus diarrhea: The IVANHOE study |
Q97565448 | Impact of rotavirus vaccination on intussusception hospital admissions in England |
Q44094211 | Impact of rotavirus vaccination on laboratory confirmed cases in Belgium |
Q38638982 | Impact of rotavirus vaccination on rotavirus and all-cause gastroenteritis in peri-urban Kenyan children |
Q64239437 | Impact of rotavirus vaccination on rotavirus genotype distribution and diversity in England, September 2006 to August 2016 |
Q41928438 | Impact of rotavirus vaccine on all-cause diarrhea and rotavirus hospitalizations in Madagascar |
Q43924082 | Impact of rotavirus vaccine on rotavirus diarrhoea in countries of East and Southern Africa |
Q64137346 | Impact of rotavirus vaccines in Sub-Saharan African countries |
Q38018979 | Impact of rotavirus vaccines on rotavirus disease |
Q43534254 | Impact of the introduction of rotavirus vaccine on the timeliness of other scheduled vaccines: the Australian experience |
Q83711221 | Impact of transmission dynamics on the cost-effectiveness of rotavirus vaccination |
Q57029745 | Impfstoffe gegen Durchfallserkrankungen – am Beispiel der Impfstoffe gegen Reisediarrhoe und gegen Rotavirus |
Q53228735 | Implementing rotavirus vaccination in Asia. |
Q39505287 | In Vitro Anti-rotaviral Activity of Achillea kellalensis. |
Q40078893 | In-season and out-of-season variation of rotavirus genotype distribution and age of infection across 12 European countries before the introduction of routine vaccination, 2007/08 to 2012/13. |
Q84431082 | Inactivated rotavirus vaccine induces protective immunity in gnotobiotic piglets |
Q37308484 | Inactivated rotavirus vaccines: a priority for accelerated vaccine development |
Q37774248 | Inadequately treated wastewater as a source of human enteric viruses in the environment |
Q33354568 | Incidence and clinical characteristics of group A rotavirus infections among children admitted to hospital in Kilifi, Kenya |
Q50029910 | Incidence and epidemiology of intussusception among children under 2 years of age in Chenzhou and Kaifeng, China, 2009-2013. |
Q34538651 | Incidence and risk factors for intussusception among children in northern Israel from 1992 to 2009: a retrospective study |
Q51140812 | Incidence of hospitalization due to community-acquired rotavirus infection: a 12-year study (1996-2008). |
Q35011035 | Incidence of intussusception in Singaporean children aged less than 2 years: a hospital-based prospective study |
Q34434552 | Incidence of rotavirus and circulating genotypes in Northeast Brazil during 7 years of national rotavirus vaccination |
Q37264906 | Incidence of rotavirus gastroenteritis by age in African, Asian and European children: Relevance for timing of rotavirus vaccination |
Q39258717 | Incidence of rotavirus gastroenteritis hospitalizations and genotypes, before and five years after introducing universal immunization in Israel. |
Q34374858 | Incorporation of a rotavirus vaccine into the national immunisation schedule in the United Kingdom: a review. |
Q36709727 | Induction of secretory immunity and memory at mucosal surfaces |
Q37284961 | Infectious diseases and vaccine sciences: strategic directions |
Q35225171 | Influence of birth rates and transmission rates on the global seasonality of rotavirus incidence |
Q38004113 | Influence of oral polio vaccines on performance of the monovalent and pentavalent rotavirus vaccines |
Q40379831 | Inhibition of rotavirus infectivity by a neoglycolipid receptor mimetic |
Q36992562 | Inhibitory effect of breast milk on infectivity of live oral rotavirus vaccines |
Q27024768 | Insights from global data for use of rotavirus vaccines in India |
Q45234850 | Interpretation of primary care physicians' attitude regarding rotavirus immunisation using diffusion of innovation theories. |
Q61804344 | Interventions to improve oral vaccine performance: a systematic review and meta-analysis |
Q43818454 | Intrarectal immunization of mice with VP6 and either LT(R192G) or CTA1-DD as adjuvant protects against fecal rotavirus shedding after EDIM challenge |
Q36918275 | Introduction of rotavirus vaccines in developing countries: remaining challenges. |
Q41050653 | Intussusception after monovalent rotavirus vaccine-United States, Vaccine Adverse Event Reporting System (VAERS), 2008-2014. |
Q98183611 | Intussusception and Kawasaki disease after rotavirus vaccination in Taiwanese infants |
Q37622904 | Intussusception and rotavirus vaccination: a review of the available evidence |
Q35896246 | Intussusception following rotavirus vaccination in the Valencia Region, Spain |
Q90625215 | Intussusception following rotavirus vaccination: a reminder for practitioners |
Q38234440 | Intussusception following rotavirus vaccination: an updated review of the available evidence |
Q56638996 | Intussusception following rotavirus vaccine administration: Post-marketing surveillance in the National Immunization Program in Australia |
Q37291708 | Intussusception hospitalizations incidence in the pediatric population in Italy: a nationwide cross-sectional study |
Q35537821 | Intussusception in Australia: epidemiology prior to the introduction of rotavirus vaccine |
Q61841114 | Intussusception in Young Children: Protocol for Multisite Hospital Sentinel Surveillance in India |
Q96586349 | Intussusception in children aged under two years in India: Retrospective surveillance at nineteen tertiary care hospitals |
Q44246038 | Intussusception in southern India: comparison of retrospective analysis and active surveillance |
Q37706379 | Intussusception incidence among infants in the UK and Republic of Ireland: a pre-rotavirus vaccine prospective surveillance study. |
Q44106887 | Intussusception risk and disease prevention associated with rotavirus vaccines in Australia's National Immunization Program. |
Q60713443 | Intussusception-associated hospitalisations in Southern Germany |
Q38714154 | Intussusception-related Hospitalizations among Infants before and after Private Market Licensure of Rotavirus Vaccines in Taiwan, 2001-2013. |
Q37694870 | Investigation of a regulatory agency enquiry into potential porcine circovirus type 1 contamination of the human rotavirus vaccine, Rotarix: approach and outcome. |
Q44275068 | Is it cost-effective to introduce rotavirus vaccination in the Dutch national immunization program? |
Q54773022 | Is nitazoxanide an effective treatment for patients with acquired immune deficiency syndrome-related cryptosporidiosis? |
Q37264972 | Issues in pediatric vaccine-preventable diseases in low- to middle-income countries |
Q46899273 | Issues with reducing the rotavirus-associated mortality by vaccination in developing countries |
Q51848206 | Keeping rotavirus vaccines on the international agenda. |
Q36851125 | Laboratory-Confirmed Rotavirus Disease in Utah Children: Clinical and Economic Impact of Rotavirus Vaccination. |
Q54385417 | Live attenuated tetravalent (G1-G4) bovine-human reassortant rotavirus vaccine (BRV-TV): Randomized, controlled phase III study in Indian infants. |
Q40451693 | Long-term Consistency in Rotavirus Vaccine Protection: RV5 and RV1 Vaccine Effectiveness in US Children, 2012-2013. |
Q98243875 | Long-term effectiveness of pentavalent and monovalent rotavirus vaccines against hospitalization in Taiwan children |
Q42205162 | Longitudinal analysis of VP7 gene of group A human rotavirus G2P[4] strains circulating in the pre-vaccine era in Sapporo, Japan from 1991 to 2011. |
Q33767570 | Maternal antibodies to rotavirus: could they interfere with live rotavirus vaccines in developing countries? |
Q90666469 | Maternal gatekeepers: How maternal antibody Fc characteristics influence passive transfer and infant protection |
Q47116194 | Maternal nutritional status during pregnancy and infant immune response to routine childhood vaccinations |
Q42264822 | Measles outbreak in a pediatric oncology unit and the role of ribavirin in prevention of complications and containment of the outbreak |
Q37145731 | Measuring the Impact of Rotavirus Acute Gastroenteritis Episodes (MIRAGE): A prospective community-based study |
Q47832199 | Methodology and lessons-learned from the efficacy clinical trial of the pentavalent rotavirus vaccine in Bangladesh |
Q35635402 | Methods and challenges in measuring the impact of national pneumococcal and rotavirus vaccine introduction on morbidity and mortality in Malawi |
Q34647668 | Mice develop effective but delayed protective immune responses when immunized as neonates either intranasally with nonliving VP6/LT(R192G) or orally with live rhesus rotavirus vaccine candidates |
Q39841648 | Modeling nosocomial transmission of rotavirus in pediatric wards. |
Q96229018 | Modeling of rotavirus transmission dynamics and impact of vaccination in Ghana |
Q39156516 | Modelling the epidemiological impact of rotavirus vaccination in Germany--a Bayesian approach. |
Q38882821 | Modelling the seasonality of rotavirus disease and the impact of vaccination in England and Wales |
Q40317040 | Modification of rotavirus multiplex RT-PCR for the detection of G12 strains based on characterization of emerging G12 rotavirus strains from South India |
Q39450402 | Molecular Analysis of VP7 Gene of Rotavirus G1 Strains Isolated from North India. |
Q40221628 | Molecular analysis of group A rotaviruses detected in adults and adolescents with severe acute gastroenteritis in Italy in 2012. |
Q37875265 | Molecular and infectivity studies of porcine circovirus in vaccines |
Q92911372 | Molecular and serologic characterization of rotavirus from children with acute gastroenteritis in northern Iran, Gorgan |
Q37410447 | Molecular characteristics of German G8P[4] rotavirus strain GER1H-09 suggest that a genotyping and subclassification update is required for G8 |
Q43996264 | Molecular characterization and analysis of equine rotavirus circulating in Japan from 2003 to 2008. |
Q42912304 | Molecular characterization of a new variant of rotavirus P[8]G9 predominant in a sentinel-based survey in central Italy. |
Q48075281 | Molecular characterization of group A human rotaviruses in Bangkok and Buriram, Thailand during 2004-2006 reveals the predominance of G1P[8], G9P[8] and a rare G3P[19] strain |
Q37695267 | Molecular characterization of rotavirus strains detected during a clinical trial of a human rotavirus vaccine in Blantyre, Malawi |
Q39730985 | Molecular characterization of rotavirus strains from children with diarrhea in Italy, 2007-2009. |
Q40254797 | Molecular epidemiology of group A rotavirus among children admitted to hospital in Salto, Uruguay, 2011-2012: first detection of the emerging genotype G12. |
Q42233115 | Molecular epidemiology of human calicivirus infections in children with acute diarrhea in Shanghai: a retrospective comparison between inpatients and outpatients treated between 2006 and 2011. |
Q38478818 | Molecular epidemiology of rotavirus diarrhea among children and adults in Nepal: detection of G12 strains with P[6] or P[8] and a G11P[25] strain |
Q41830616 | Molecular epidemiology of rotavirus diarrhea among children in Saudi Arabia: first detection of G9 and G12 strains. |
Q43927864 | Molecular epidemiology of rotaviruses in Bulgaria: annual shift of the predominant genotype. |
Q43936551 | Monitoring impact and effectiveness of rotavirus vaccination |
Q38903526 | Monitoring of rotavirus vaccination in Morocco: establishing the baseline burden of rotavirus disease |
Q54094430 | Monitoring shedding of five genotypes of RotaTeq vaccine viruses by genotype-specific real-time RT-PCR assays. |
Q37150315 | Monitoring the impact of vaccines postlicensure: new challenges, new opportunities |
Q37559647 | Mucosal vaccines: novel advances in technology and delivery |
Q38463606 | Multiple virus infection alters rotavirus replication and expression of cytokines and Toll-like receptors in intestinal epithelial cells |
Q41078001 | Multiplexed one-step RT-PCR VP7 and VP4 genotyping assays for rotaviruses using updated primers |
Q36993936 | Mutation distribution in the NSP4 protein in rotaviruses isolated from Mexican children with moderate to severe gastroenteritis |
Q36791315 | Neonatal infection with G10P[11] rotavirus did not confer protection against subsequent rotavirus infection in a community cohort in Vellore, South India |
Q38883770 | New Horizons in the Development of Novel Needle-Free Immunization Strategies to Increase Vaccination Efficacy |
Q38255552 | New approaches in oral rotavirus vaccines |
Q37880425 | New approaches to the assessment of vaccine herd protection in clinical trials |
Q36552854 | New insights into rotavirus vaccines. |
Q37370235 | Non-structural protein NSP2 induces heterotypic antibody responses during primary rotavirus infection and reinfection in children |
Q33652978 | Nosocomial Rotavirus Gastroenteritis in pediatric patients: a multi-center prospective cohort study. |
Q36983970 | Nosocomial rotavirus gastroenterocolitis in a large tertiary paediatric hospital in Warsaw, 2006-2010. |
Q43334028 | One year environmental surveillance of rotavirus specie A (RVA) genotypes in circulation after the introduction of the Rotarix® vaccine in Rio de Janeiro, Brazil |
Q30241442 | Options for improving effectiveness of rotavirus vaccines in developing countries. |
Q36903971 | Oral rotavirus vaccines: how well will they work where they are needed most? |
Q36892043 | Oral vaccines: directed safe passage to the front line of defense |
Q37694876 | Overcoming perceptions of financial barriers to rotavirus vaccine introduction in Asia |
Q38654728 | Ovine rotaviruses |
Q41733628 | Parental preferences for rotavirus vaccination in young children: a discrete choice experiment. |
Q81548527 | Parenteral administration of RF 8-2/6/7 rotavirus-like particles in a one-dose regimen induce protective immunity in mice |
Q40210004 | Parenteral protein-based rotavirus vaccine |
Q92662284 | Pathogen-Specific Impacts of the 2011-2012 La Niña-Associated Floods on Enteric Infections in the MAL-ED Peru Cohort: A Comparative Interrupted Time Series Analysis |
Q37762246 | Pentavalent rotavirus vaccine (RotaTeq): a review of its use in the prevention of rotavirus gastroenteritis in Europe |
Q24600612 | Performance of rotavirus vaccines in developed and developing countries |
Q38194216 | Perspectives on the future of postmarket vaccine safety surveillance and evaluation |
Q36650016 | Pharmacoeconomic spotlight on rotavirus vaccine RIX4414 (Rotarix™) in developed countries |
Q38046665 | Pharmacoeconomic spotlight on rotavirus vaccine RIX4414 (Rotarix™) in the prevention of rotavirus gastroenteritis in developing countries |
Q51692593 | Phylodynamic analyses of rotavirus genotypes G9 and G12 underscore their potential for swift global spread. |
Q46367207 | Phylogenetic and computational structural analysis of VP7 gene of group a human rotavirus G1P[8] strains obtained in Sapporo, Japan from 1987 to 2000. |
Q47298440 | Phylogenetic comparison of the VP7, VP4, VP6, and NSP4 genes of rotaviruses isolated from children in Nizhny Novgorod, Russia, 2015-2016, with cogent genes of the Rotarix and RotaTeq vaccine strains. |
Q64125113 | Polio endgame: Lessons for the global rotavirus vaccination program |
Q36781547 | Population Impact and Effectiveness of Monovalent Rotavirus Vaccination in Urban Malawian Children 3 Years After Vaccine Introduction: Ecological and Case-Control Analyses |
Q51138986 | Population-based surveillance for severe rotavirus gastroenteritis in children in Karachi, Pakistan. |
Q39251840 | Porcine Circoviruses and Xenotransplantation |
Q36531176 | Post-marketing monitoring of intussusception after rotavirus vaccination in Japan. |
Q37375887 | Post-marketing safety surveillance conducted in Korea (2008-2013) following the introduction of the rotavirus vaccine, RIX4414 (Rotarix™). |
Q51143331 | Potential epidemiological and economical impact of two rotavirus vaccines in Colombia. |
Q47422430 | Potential for a booster dose of rotavirus vaccine to further reduce diarrhea mortality |
Q45822805 | Potential intussusception risk versus benefits of rotavirus vaccination in the United States |
Q48002125 | Potential intussusception risk versus health benefits from rotavirus vaccination in Latin America |
Q40693674 | Potential safety issues and other factors that may affect the introduction and uptake of rotavirus vaccines |
Q42685766 | Pre-vaccine circulating group a rotavirus strains in under 5 years children with acute diarrhea during 1999-2013 in Cameroon |
Q90214218 | Precision immunization: a new trend in human vaccination |
Q89843470 | Predictors of oral rotavirus vaccine immunogenicity in rural Zimbabwean infants |
Q33776603 | Predominance of rotavirus P[4]G2 in a vaccinated population, Brazil |
Q38202176 | Preparing for dengue vaccine introduction in ASEAN countries: recommendations from the first ADVA regional workshop |
Q47422424 | Preparing for rotavirus vaccine introduction - A retrospective assessment of the epidemiology of intussusception in children below 2 years of age in Nepal. |
Q58603388 | Preparing for safety monitoring after rotavirus vaccine introduction - Assessment of baseline epidemiology of intussusception among children <2 years of age in four Asian countries |
Q33583571 | Prevalence and genetic diversity of rotavirus infection in children with acute gastroenteritis in a hospital setting, Nairobi Kenya in post vaccination era: a cross-sectional study |
Q36124358 | Prevalence and genotype distribution of rotaviruses in children with gastroenteritis in Rize province. |
Q39790465 | Prevalence of G2P[4] and G12P[6] rotavirus, Bangladesh |
Q35854529 | Prevention and Control of Childhood Pneumonia and Diarrhea |
Q34616273 | Prevention and treatment of viral diarrhea in pediatrics |
Q37012078 | Prevention of childhood rotavirus disease through the use of Rotarix and RotaTeq vaccines |
Q34064371 | Prevention of rotavirus gastroenteritis in infants and children: rotavirus vaccine safety, efficacy, and potential impact of vaccines |
Q43784089 | Progress with rotavirus vaccines: summary of the Tenth International Rotavirus Symposium |
Q47832226 | Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030. |
Q45202354 | Projected health impact and cost-effectiveness of rotavirus vaccination among children <5 years of age in China |
Q40122963 | Projecting vaccine efficacy: accounting for geographic strain variations. |
Q48690061 | Prospective study of the burden of rotavirus gastroenteritis in Danish children and their families |
Q35941247 | Protection against live rotavirus challenge in mice induced by parenteral and mucosal delivery of VP6 subunit rotavirus vaccine |
Q34203915 | Protective effect of natural rotavirus infection in an Indian birth cohort |
Q37363974 | Public health impact and cost effectiveness of mass vaccination with live attenuated human rotavirus vaccine (RIX4414) in India: model based analysis |
Q34291218 | Public health impact of accelerated immunization against rotavirus infection among children aged less than 6 months in the United States |
Q40489579 | Qualitative Effects of Monovalent Vaccination Against Rotavirus: A Comparison of North America and South America |
Q60179829 | Quantification of Rotavirus Diarrheal Risk Due to Hydroclimatic Extremes Over South Asia: Prospects of Satellite-Based Observations in Detecting Outbreaks |
Q91975985 | Quantitative Benefit-Risk Models Used for Rotavirus Vaccination: A Systematic Review |
Q33901553 | Rapid changes in rotaviral genotypes in Ecuador |
Q41285657 | Rapid impact of rotavirus vaccine introduction to the National Immunization plan in southern Israel: comparison between 2 distinct populations |
Q60910627 | Rates of hospitalization and death for all-cause and rotavirus acute gastroenteritis before rotavirus vaccine introduction in Kenya, 2010-2013 |
Q36978426 | Reactogenicity and safety of the human rotavirus vaccine, Rotarix™ in The Philippines, Sri Lanka, and India: a post-marketing surveillance study |
Q50776961 | Ready to Measure Impact? The Introduction of Rotavirus Vaccine in India. |
Q38089933 | Real-time quantitative polymerase chain reaction for virus infection diagnostics |
Q98625964 | Real-world effectiveness of rotavirus vaccines, 2006-19: a literature review and meta-analysis |
Q38029250 | Recent progress in mucosal vaccine development: potential and limitations |
Q80607738 | Recombinant rotavirus inner core proteins produced in the milk of transgenic rabbits confer a high level of protection after intrarectal delivery |
Q94420965 | Recommandations sur l’utilisation du vaccin antirotavirus chez les nourrissons |
Q30843515 | Recommendation of rotavirus vaccination and herd effect: a budget impact analysis based on German health insurance data |
Q34115573 | Recommendations for rotavirus vaccination: A worldwide perspective |
Q34187771 | Recommendations for the use of rotavirus vaccines in infants |
Q87889452 | Recommendations for the use of rotavirus vaccines in infants |
Q37975416 | Reduction in morbidity and mortality from childhood diarrhoeal disease after species A rotavirus vaccine introduction in Latin America - a review |
Q37723321 | Relationship between Pentavalent Rotavirus Vaccine and Intussusception: A Retrospective Study at a Single Center in Korea |
Q37981766 | Remaining issues and challenges for rotavirus vaccine in preventing global childhood diarrheal morbidity and mortality |
Q28484524 | Removing the age restrictions for rotavirus vaccination: a benefit-risk modeling analysis |
Q44516472 | Research priorities regarding rotavirus vaccine and intussusception: a meeting summary |
Q40405465 | Resurgence of Rotavirus Genotype G12 in St. Louis During the 2014-2015 Rotavirus Season |
Q36527126 | Rethinking global access to vaccines |
Q38004110 | Retrospective hospital based surveillance of intussusception in children in a sentinel paediatric hospital: benefits and pitfalls for use in post-marketing surveillance of rotavirus vaccines |
Q89801615 | Retrospective study of the use of an influenza disease two-tiered classification system to characterize clinical severity in US children |
Q38236883 | Retrospective surveillance for intussusception in children aged less than five years at two tertiary care centers in India |
Q38970217 | Review of Naturally Occurring Intussusception in Young Children in the WHO African Region prior to the Era of Rotavirus Vaccine Utilization in the Expanded Programme of Immunization |
Q37123967 | Rice-based oral antibody fragment prophylaxis and therapy against rotavirus infection. |
Q33654119 | Risk of Intussusception After Rotavirus Vaccination |
Q48348851 | Risk of Intussusception with Rotavirus Vaccine. |
Q99710176 | Risk of intussusception after monovalent rotavirus vaccine (Rotavac) in Indian infants: A self-controlled case series analysis |
Q33601981 | Robustness of the healthcare utilization results from the Rotavirus Efficacy and Safety Trial (REST) evaluating the human-bovine (WC3) reassortant pentavalent rotavirus vaccine (RV5) |
Q43223298 | Role of antidiarrhoeal drugs as adjunctive therapies for acute diarrhoea in children. |
Q84824069 | RotaTeq, a pentavalent rotavirus vaccine: efficacy and safety among infants in Europe |
Q34574852 | Rotarix (RIX4414): an oral human rotavirus vaccine |
Q42775398 | Rotarix in Japan: Expectations and Concerns |
Q34900447 | Rotarix: a rotavirus vaccine for the world |
Q37956376 | Rotarix®: vaccine performance 6 years postlicensure |
Q42248692 | Rotavirus G and P types circulating in the eastern region of Kenya: predominance of G9 and emergence of G12 genotypes |
Q64132496 | Rotavirus Gastroenteritis Infection Among Children Vaccinated and Unvaccinated With Rotavirus Vaccine in Southern China: A Population-Based Assessment |
Q36116057 | Rotavirus Genotypes and Vaccine Effectiveness from a Sentinel, Hospital-Based, Surveillance Study for Three Consecutive Rotavirus Seasons in Lebanon |
Q27009028 | Rotavirus Infection in Children with Acute Gastroenteritis in Iran: A Systematic Review and Meta-analysis |
Q45850756 | Rotavirus P[4]G2 in a Vaccinated Population, Brazil. |
Q43230392 | Rotavirus P[4]G2 in a vaccinated population, Brazil |
Q114371368 | Rotavirus Spike Protein VP4 Mediates Viroplasm Assembly by Association to Actin Filaments |
Q38994750 | Rotavirus Vaccination in India - Need for Surveillance of Intussusception |
Q40048009 | Rotavirus Vaccine Response Correlates with the Infant Gut Microbiota Composition in Pakistan |
Q47547296 | Rotavirus Vaccines: Effectiveness, Safety, and Future Directions |
Q41589121 | Rotavirus Vaccines: a story of success with challenges ahead |
Q59712369 | Rotavirus and not age determines gastroenteritis severity in children: a hospital-based study |
Q36520401 | Rotavirus and rotavirus vaccines |
Q39290987 | Rotavirus anti-VP6 secretory immunoglobulin A contributes to protection via intracellular neutralization but not via immune exclusion. |
Q34715515 | Rotavirus diarrhoea and future prospects for prevention |
Q40338858 | Rotavirus differentially infects and polyclonally stimulates human B cells depending on their differentiation state and tissue of origin |
Q37648707 | Rotavirus disease and vaccination: impact on genotype diversity |
Q51829359 | Rotavirus disease and vaccines in India: a tremendous public health opportunity. |
Q24632674 | Rotavirus diversity and evolution in the post-vaccine world |
Q40379989 | Rotavirus epidemiology 5-6 years after universal rotavirus vaccination: persistent rotavirus activity in older children and elderly |
Q43365960 | Rotavirus epidemiology and vaccine demand: considering Bangladesh chapter through the book of global disease burden. |
Q37165954 | Rotavirus epidemiology: the Asian Rotavirus Surveillance Network. |
Q54413323 | Rotavirus gastroenteritis in Finnish children in 2006–2008, at the introduction of rotavirus vaccination |
Q33494098 | Rotavirus gastroenteritis in Norway: analysis of prospective surveillance and hospital registry data |
Q37089143 | Rotavirus gastroenteritis in children under 5 years in the Kingdom of Bahrain: hospital-based surveillance |
Q34071302 | Rotavirus genetic diversity, disease association, and temporal change in hospitalized rural Kenyan children |
Q37139895 | Rotavirus genotype distribution after vaccine introduction, Rio de Janeiro, Brazil |
Q59350430 | Rotavirus genotypes circulating in Ontario, Canada, before and after implementation of the rotavirus immunization program |
Q36864908 | Rotavirus genotypes in Malaysia and universal rotavirus vaccination |
Q47549229 | Rotavirus hospitalizations among children <5 years of age-Tajikistan, 2013-2014. |
Q36173819 | Rotavirus immune responses and correlates of protection |
Q38952955 | Rotavirus immunization: Global coverage and local barriers for implementation |
Q56762709 | Rotavirus in Latin America: Current Situation and Perspectives |
Q39836378 | Rotavirus incidence and genotype distribution before and after national rotavirus vaccine introduction in Belgium |
Q46152582 | Rotavirus infection |
Q30252454 | Rotavirus infection and disease in a multi-site birth cohort: Results from the MAL-ED study |
Q43581428 | Rotavirus infection and its genetic characterization in non-hospitalized adults with acute gastroenteritis in Shanghai, China |
Q35185921 | Rotavirus infection enhances lipopolysaccharide-induced intussusception in a mouse model |
Q84356433 | Rotavirus infection in a tertiary hospital: laboratory diagnosis and impact of immunization on pediatric hospitalization |
Q44736456 | Rotavirus infection in hospitalized children and estimates of disease burden in Kyrgyzstan, 2005-2007. |
Q36550022 | Rotavirus infection: a perspective on epidemiology, genomic diversity and vaccine strategies |
Q28270926 | Rotavirus infection: an update on management and prevention |
Q37769212 | Rotavirus infections and vaccines: burden of illness and potential impact of vaccination |
Q39639810 | Rotavirus infections in Detroit, USA, a region of low vaccine prevalence. |
Q36316511 | Rotavirus mortality in India: estimates based on a nationally representative survey of diarrhoeal deaths |
Q24299094 | Rotavirus nonstructural protein 1 antagonizes innate immune response by interacting with retinoic acid inducible gene I |
Q40393201 | Rotavirus specific maternal antibodies and immune response to RV3-BB neonatal rotavirus vaccine in New Zealand |
Q47569749 | Rotavirus strain diversity in Eastern and Southern African countries before and after vaccine introduction |
Q44329839 | Rotavirus strain surveillance--an Australian perspective of strains causing disease in hospitalised children from 1997 to 2007. |
Q37588132 | Rotavirus strategies to evade host antiviral innate immunity |
Q33812698 | Rotavirus surveillance in Kisangani, the Democratic Republic of the Congo, reveals a high number of unusual genotypes and gene segments of animal origin in non-vaccinated symptomatic children |
Q37375904 | Rotavirus vaccination and intussusception - Science, surveillance, and safety: A review of evidence and recommendations for future research priorities in low and middle income countries |
Q101163376 | Rotavirus vaccination and stunting: Secondary Data Analysis from the Peruvian Demographic and Health Survey |
Q42288802 | Rotavirus vaccination effectiveness: a case-case study in the EDICS project, Castellón (Spain). |
Q38168901 | Rotavirus vaccination in Brazil: effectiveness and health impact seven years post-introduction |
Q38206627 | Rotavirus vaccination in Europe: drivers and barriers. |
Q38039610 | Rotavirus vaccination within the South African Expanded Programme on Immunisation. |
Q79416539 | Rotavirus vaccine RIX4414 (Rotarix) |
Q37363968 | Rotavirus vaccine RIX4414 (Rotarix): a review of its use in the prevention of rotavirus gastroenteritis |
Q37866754 | Rotavirus vaccine RIX4414 (Rotarix™): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developed countries |
Q37944318 | Rotavirus vaccine RIX4414 (Rotarix™): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developing countries |
Q40030087 | Rotavirus vaccine RIX4414 efficacy sustained during the third year of life: a randomized clinical trial in an Asian population |
Q37671534 | Rotavirus vaccine and health-care utilization for rotavirus gastroenteritis in Tsu City, Japan |
Q28727365 | Rotavirus vaccine and intussusception |
Q40551811 | Rotavirus vaccine effectiveness in Hong Kong children |
Q38445983 | Rotavirus vaccine effectiveness in Latin American and Caribbean countries: A systematic review and meta-analysis |
Q64087810 | Rotavirus vaccine impact assessment surveillance in India: protocol and methods |
Q44915328 | Rotavirus vaccine introduction in the Americas: progress and lessons learned |
Q53392521 | Rotavirus vaccine series completion and adherence to vaccination schedules among infants in managed care in the United States. |
Q40873450 | Rotavirus vaccine stability in the aquatic environment |
Q42550670 | Rotavirus vaccine: a promise for the future. |
Q56988239 | Rotavirus vaccines |
Q24654275 | Rotavirus vaccines and pathogenesis: 2008 |
Q39187401 | Rotavirus vaccines contribute towards universal health coverage in a mixed public-private healthcare system |
Q40298217 | Rotavirus vaccines in Israel: Uptake and impact. |
Q38004112 | Rotavirus vaccines in developing countries: the potential impact, implementation challenges, and remaining questions |
Q26853690 | Rotavirus vaccines in routine use |
Q79957957 | Rotavirus vaccines must perform in low-income countries too |
Q41511734 | Rotavirus vaccines roll-out in resource-deprived regions |
Q47119066 | Rotavirus vaccines--balancing intussusception risks and health benefits |
Q24657750 | Rotavirus vaccines: an overview |
Q79379362 | Rotavirus vaccines: considerations for successful implementation in Europe |
Q34550164 | Rotavirus vaccines: current prospects and future challenges |
Q27021385 | Rotavirus vaccines: current status and future considerations |
Q37081817 | Rotavirus vaccines: how they work or don't work |
Q36850161 | Rotavirus vaccines: recent developments and future considerations. |
Q45165657 | Rotavirus vaccines: safety, efficacy and public health impact |
Q94947290 | Rotavirus vaccines: the role of researchers in moving evidence to action |
Q35918823 | Rotavirus vaccines: update on global impact and future priorities |
Q37298870 | Rotavirus vaccines: viral shedding and risk of transmission |
Q59360403 | Rotavirus vaccines: why continued investment in research is necessary |
Q58289569 | Rotavirus vaccines—An update |
Q45326050 | Rotavirus virus-like particles (RV-VLPs) vaccines: An update |
Q39589705 | Rotavirus within day care centres in Oxfordshire, UK: characterization of partial immunity. |
Q40479048 | Rotavirus, vaccine failure or diagnostic error? |
Q61700314 | Rotavirus: realising the potential of a promising vaccine |
Q42915828 | Rotavirus: the challenges ahead |
Q26996393 | Rotaviruses |
Q33990547 | Rotaviruses associate with cellular lipid droplet components to replicate in viroplasms, and compounds disrupting or blocking lipid droplets inhibit viroplasm formation and viral replication. |
Q24609374 | Rotaviruses: from pathogenesis to vaccination |
Q36518775 | Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules |
Q56787285 | Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: Randomised, double-blind, controlled study |
Q40141433 | Safety and immunogenicity of RV3-BB human neonatal rotavirus vaccine administered at birth or in infancy: a randomised, double-blind, placebo-controlled trial |
Q38797322 | Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo-controlled trial |
Q27013956 | Safety assessment of adjuvanted vaccines: Methodological considerations |
Q37187396 | Safety of live, attenuated oral vaccines in HIV-infected Zambian adults: oral vaccines in HIV |
Q37992392 | Safety reporting in developing country vaccine clinical trials-a systematic review |
Q52658436 | Safety study of live, oral human rotavirus vaccine: A cohort study in United States health insurance plans. |
Q27487961 | Sang Froid in a time of trouble: is a vaccine against HIV possible? |
Q24651505 | Seasonality of rotavirus disease in the tropics: a systematic review and meta-analysis |
Q34307501 | Sentinel hospital-based surveillance for assessment of burden of rotavirus gastroenteritis in children in Pakistan |
Q42201947 | Sequence analysis of VP7 and VP4 genes of G1P[8] rotaviruses circulating among diarrhoeic children in Pune, India: a comparison with Rotarix and RotaTeq vaccine strains |
Q54356989 | Sequence analysis of human rotavirus strains: comparison of clinical isolates from Northern and Southern Italy. |
Q37619157 | Serologic response to porcine circovirus type 1 (PCV1) in infants vaccinated with the human rotavirus vaccine, Rotarix™: A retrospective laboratory analysis |
Q44488487 | Severity of rotavirus gastroenteritis in Indian children requiring hospitalization |
Q92158537 | Shedding of oral pentavalent bovine-human reassortant rotavirus vaccine indicates high uptake rate of vaccine and prominence of G-type G1 |
Q47131606 | Should India launch a national immunisation programme against rotavirus? Yes. |
Q36179680 | Significant Correlation Between the Infant Gut Microbiome and Rotavirus Vaccine Response in Rural Ghana |
Q36996665 | Study on Rotavirus Infection and Its Genotyping in Children Below 5 Years in South West Iran |
Q57936381 | Successful co-administration of a human rotavirus and oral poliovirus vaccines in Bangladeshi infants in a 2-dose schedule at 12 and 16 weeks of age |
Q24197707 | Surgical and non-surgical management for intussusception in children |
Q24246078 | Surgical and non-surgical management for intussusception in children |
Q36450198 | Surveillance and molecular characterization of group A rotaviruses in Goroka, Papua New Guinea |
Q40530316 | Sustained High Effectiveness of RotaTeq on Hospitalizations Attributable to Rotavirus-Associated Gastroenteritis During 4 Years in Finland. |
Q40722641 | Sustained Reduction of Childhood Diarrhea-Related Mortality and Hospitalizations in Mexico After Rotavirus Vaccine Universalization |
Q39343850 | Sustained low hospitalization rates after four years of rotavirus mass vaccination in Austria |
Q28305259 | Symptomatic and subclinical infection with rotavirus P[8]G9, rural Ecuador |
Q38236881 | Synthesizing evidences for policy translation: a public health discourse on rotavirus vaccine in India |
Q38115368 | Systematic documentation of new vaccine introduction in selected countries of the Latin American Region |
Q38004108 | Systematic review of regional and temporal trends in global rotavirus strain diversity in the pre rotavirus vaccine era: insights for understanding the impact of rotavirus vaccination programs. |
Q34659711 | Systemic rotavirus infection |
Q40722593 | Temporal Association of Rotavirus Vaccine Introduction and Reduction in All-Cause Childhood Diarrheal Hospitalizations in South Africa |
Q90273310 | Temporal decline in diarrhea episodes and mortality in Kiribati children two years following rotavirus vaccine introduction, despite high malnutrition rates: a retrospective review |
Q33792227 | Th17 cytokines and vaccine-induced immunity |
Q37628867 | The ABC of clinical and experimental adjuvants--a brief overview |
Q30382403 | The Immunologic Complexity of Growing Up with Malaria--Is Scientific Understanding Coming of Age? |
Q37600173 | The Safety and Immunogenicity of Rotavirus Vaccination in Infants With Intestinal Failure. |
Q37444783 | The Sustained Rotavirus Vaccination Impact on Nosocomial Infection, Duration of Hospital Stay, and Age: The RotaBIS Study (2005-2012). |
Q82673369 | The burden of rotavirus gastroenteritis in children presenting to a paediatric hospital |
Q84615729 | The burden of rotavirus hospitalizations among Medicaid and non-Medicaid children younger than 5 years old |
Q26770871 | The clinical development process for a novel preventive vaccine: An overview |
Q36519692 | The control of rotavirus gastroenteritis in the United States |
Q37135008 | The cost effectiveness of rotavirus vaccination in Iran |
Q38045661 | The cost-effectiveness of pentavalent rotavirus vaccination in England and Wales |
Q44902395 | The cost-effectiveness of rotavirus vaccination in Australia |
Q80539552 | The cost-utility of rotavirus vaccination with Rotarix (RIX4414) in the Netherlands |
Q46309096 | The detection and molecular characterization of human G12 genotypes in South Africa |
Q92639992 | The distinct impact of maternal antibodies on the immunogenicity of live and recombinant rotavirus vaccines |
Q53078390 | The economic burden of rotavirus infection in South Korea from 2009 to 2012. |
Q37815575 | The effect of rotavirus immunization on rotavirus gastroenteritis hospitalization rates in military dependents |
Q33754470 | The effect of rotavirus vaccine on diarrhoea mortality |
Q53096855 | The effect of routine rotavirus vaccination on healthcare utilization for diarrhea in US children. |
Q40919777 | The effectiveness of a rotavirus vaccine in preventing hospitalizations and deaths presumably due to acute infectious diarrhea in Brazilian children: a quasi-experimental study. |
Q36958313 | The effectiveness of rotavirus vaccine in preventing acute gastroenteritis during rotavirus seasons among Polish children |
Q61804842 | The evolving epidemiology of rotavirus A infection in Brazil a decade after the introduction of universal vaccination with Rotarix® |
Q54250697 | The future control of rotavirus disease: Can live oral vaccines alone solve the rotavirus problem? |
Q38172132 | The gastrointestinal frontier: IgA and viruses |
Q38551946 | The health and economic burden of rotavirus disease in Belgium |
Q39184168 | The impact of rotavirus vaccination on emergency department visits and hospital admissions for acute diarrhea in children under 5 years |
Q36953332 | The influence of CD4+ CD25+ Foxp3+ regulatory T cells on the immune response to rotavirus infection |
Q57530932 | The occurrence of amino acid substitutions D96N and S242N in VP7 of emergent G2P[4] rotaviruses in Nepal in 2004-2005: a global and evolutionary perspective |
Q40057091 | The porcine virome and xenotransplantation |
Q39067681 | The practice of travel medicine: guidelines by the Infectious Diseases Society of America |
Q39693124 | The risk of intussusception following monovalent rotavirus vaccination in England: A self-controlled case-series evaluation |
Q46678108 | The rotavirus experience in Mexico: discovery to control |
Q39232838 | The rotavirus vaccine development pipeline. |
Q38048555 | The status of live viral vaccination in early life |
Q38009581 | The unpredictable diversity of co-circulating rotavirus types in Europe and the possible impact of universal mass vaccination programmes on rotavirus genotype incidence |
Q44811562 | The uptake of rotavirus vaccine and its effectiveness in preventing acute gastroenteritis in the community |
Q36490234 | The use of cost-effectiveness analysis for pediatric immunization in developing countries |
Q33750837 | The use of immunization registry-based data in vaccine effectiveness studies |
Q42204913 | Timely immunisation of premature infants against rotavirus in the neonatal intensive care unit. |
Q52643114 | Timing and predictors of severe rotavirus gastroenteritis among unvaccinated infants in low- and middle-income countries. |
Q55043303 | Transcutaneous immunization with the heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC): protective efficacy in a double-blind, placebo-controlled challenge study. |
Q42234885 | Transplacental rotavirus IgG interferes with immune response to live oral rotavirus vaccine ORV-116E in Indian infants |
Q91989138 | Travelers' Diarrhea: A Clinical Review |
Q42269528 | Treatment and prevention of rotavirus infection in children |
Q40575373 | Trends in severe gastroenteritis among young children according to socio-economic characteristics before and after implementation of a rotavirus vaccination program in Quebec. |
Q39353594 | Unbiased whole-genome deep sequencing of human and porcine stool samples reveals circulation of multiple groups of rotaviruses and a putative zoonotic infection |
Q34374045 | Understanding reduced rotavirus vaccine efficacy in low socio-economic settings |
Q44573092 | Unexpected benefits of rotavirus vaccination in the United States |
Q41251470 | Unexpected spreading of G12P[8] rotavirus strains among young children in a small area of central Italy. |
Q33601897 | Unexpectedly high burden of rotavirus gastroenteritis in very young infants |
Q37640107 | Update on Rotarix: an oral human rotavirus vaccine |
Q36593011 | Uptake of oral rotavirus vaccine and timeliness of routine immunization in Brazil's National Immunization Program |
Q40722670 | Use of Patients With Diarrhea Who Test Negative for Rotavirus as Controls to Estimate Rotavirus Vaccine Effectiveness Through Case-Control Studies |
Q50937053 | Use of Surveillance Data to Assess the Impact of Vaccination on Circulating Rotavirus Strains. |
Q21257223 | Use of formative research in developing a knowledge translation approach to rotavirus vaccine introduction in developing countries |
Q45685379 | Use of intravenous fluids in Hong Kong children hospitalised for diarrhoea and relationship to severity and aetiology |
Q38714968 | VP4- and VP7-specific antibodies mediate heterotypic immunity to rotavirus in humans. |
Q24648884 | Vaccination greatly reduces disease, disability, death and inequity worldwide |
Q35591138 | Vaccination recommendations for Germany |
Q28080866 | Vaccines against enteric infections for the developing world |
Q34572829 | Vaccines against traveler's diarrhoea and rotavirus disease - a review. |
Q91767150 | Vaccines for enteric diseases |
Q64117280 | Vaccines for preventing rotavirus diarrhoea: vaccines in use |
Q24197495 | Vaccines for preventing rotavirus diarrhoea: vaccines in use |
Q24203645 | Vaccines for preventing rotavirus diarrhoea: vaccines in use |
Q24235411 | Vaccines for preventing rotavirus diarrhoea: vaccines in use |
Q27004488 | Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part I: Overview, vaccines for enteric viruses and Vibrio cholerae |
Q43595566 | Vaccines: The real issues in vaccine safety |
Q37058335 | Vaccines: the pentavalent rotavirus vaccine: discovery to licensure and beyond |
Q37211315 | Validation of the modified Vesikari score in children with gastroenteritis in 5 US emergency departments |
Q30977508 | Value of post-licensure data on benefits and risks of vaccination to inform vaccine policy: The example of rotavirus vaccines |
Q30376550 | Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines. |
Q91909593 | Viral gastroenteritis |
Q91909624 | Viral gastroenteritis |
Q33602861 | Virulence-associated genome mutations of murine rotavirus identified by alternating serial passages in mice and cell cultures |
Q24596833 | Water, sanitation, hygiene and enteric infections in children |
Q44362569 | What do policy makers need to know? Lessons from the decision to add pneumococcal conjugate and rotavirus vaccines to the US immunization program |
Q48055892 | Whole genome analyses of African G2, G8, G9, and G12 rotavirus strains using sequence-independent amplification and 454® pyrosequencing |
Q42217823 | Whole genome analyses of G1P[8] rotavirus strains from vaccinated and non-vaccinated South African children presenting with diarrhea. |
Q35181316 | Whole genome detection of rotavirus mixed infections in human, porcine and bovine samples co-infected with various rotavirus strains collected from sub-Saharan Africa |
Q44474941 | Whole genome sequencing of lamb rotavirus and comparative analysis with other mammalian rotaviruses |
Q36822928 | Why does the world need another rotavirus vaccine? |
Q44045362 | Workshop on intussusception in African countries--meeting report. |
Q90783116 | Would immunization be the same without cross-reactivity? |
Q35005253 | Zoonotic aspects of rotaviruses |
Q52591259 | [Family impact of rotavirus gastroenteritis in children under two years]. |
Q81502330 | [Rotavirus vaccination in France: recommendations of the French Speaking Group of Pediatric Gastroenterology, Hepatology and Nutrition] |
Search more.